What is Usana Health Sciences Inc worth?
With the base-case assumptions below, a discounted cash flow model on Usana Health Sciences Inc's reported free cash flow gives $14.03 per share. The share price was $14.50 on September 25, 2026, 3% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | -9.0% | 10.0% | $12.21 | -16% |
| Base | -4.0% | 9.0% | $14.03 | -3% |
| Bull | 1.0% | 8.0% | $17.43 | +20% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $15.26 | $15.62 | $16.06 | $16.61 | $17.32 |
| 8.0% | $14.35 | $14.59 | $14.86 | $15.20 | $15.60 |
| 9.0% | $13.69 | $13.85 | $14.03 | $14.25 | $14.50 |
| 10.0% | $13.18 | $13.29 | $13.42 | $13.57 | $13.74 |
| 11.0% | $12.77 | $12.86 | $12.95 | $13.06 | $13.17 |
Where the presets come from
Base: years 1 to 5 grow at Usana Health Sciences Inc's revenue growth rate over the last 5 fiscal years (-4.0% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions